Xeris Biopharma to Participate at the Jefferies Healthcare Conference ...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 23, 2024

TELUS Health 2024 Drug Trends Report: Diabetes medications maintain top reimbursed expense position; ADHD drugs surge • HGreg Joins Forces With Tree Canada for an 8th Consecutive Year • Brookdale Announces Date of First Quarter 2024 Earnings Release and Conference Call • Northeast Delta HSA collaborates with AKA chapter for Earth Day, plants tree to symbolize RISE Center • Zurn Elkay Water Solutions Reports First Quarter 2024 Financial Results • Tesla Releases First Quarter 2024 Financial Results • AccountTECH unveils revolutionary Cloud-Based Enterprise Accounting software at the T3 Leadership Summit • Avangrid First Quarter 2024 Financial Results Available on Company’s Website • Voto Latino Announces Honorees for 16th Annual Our Voices Celebration • Minister Sudds highlights budget investments in support of Indigenous Reconciliation • iHeartMedia and Deep Blue Sports + Entertainment Launch Women’s Sports Audio Network – The First-Ever Audio Platform • Dr. Anthony Fletcher Installed as President of the Association of Black Cardiologists • AudioEye Reports Record First Quarter 2024 Results • Experience Senior Living Celebrates the Opening of the new Independent Living community at The Gallery at Cape Coral • Carter’s, Inc. to Report First Quarter Fiscal 2024 Results on Friday, April 26, 2024 • PENN Entertainment Publishes 2023 Corporate Social Responsibility Report • Coeur Publishes 2023 ESG Report • Popilush Introduces Bluetag COOLING Collection with Body-Cooling Technology • American Foundation for Suicide Prevention Statement on the Release of the 2024 National Strategy for Suicide Prevention • Empire State Realty Trust Publishes 2023 Sustainability Report with Major Achievements, Key Goals, and Transparent Metrics

Xeris Biopharma to Participate at the Jefferies Healthcare Conference

CHICAGO , June 01 /Businesswire/ - Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that members of its senior management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 8 at 10:30am Eastern Time.

A live webcast of the event will be available on the 'Events & Presentations' section of Xeris’ Investor Relations website at https://xerispharma.com/investor-relations or https://wsw.com/webcast/jeff281/xers/1879020. A replay of the webcast will be available for 60 days.

About Xeris

Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing differentiated and innovative products across a range of therapies. Xeris has three commercially available products: Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; Keveyis®, a proven therapy for primary periodic paralysis; and Recorlev® for the treatment of endogenous Cushing’s syndrome. Xeris has a pipeline of development and partnered programs using its formulation sciences, XeriSol™ and XeriJect™, to support long-term product development and commercial success.

Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow Xeris on Twitter, LinkedIn or Instagram.